Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

NCT00091156 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

598

Enrollment

NETWORK

Sponsor class

Stopped low accrual

Conditions

Lung Cancer

Interventions

DRUG: gefitinib
PROCEDURE: adjuvant therapy

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC